ARTA
AXSM icon

A.R.T. Advisors’s Axsome Therapeutics AXSM Stock Holding History

A.R.T. Advisors’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-19,428
Closed -$393K – 1330
2019
Q3 		$393K Buy
+19,428
New +$499K 0.02% 948
2018
Q3 		– Sell
-21,592
Closed -$69K – 1398
2018
Q2 		$69K Sell
21,592
-37,690
-64% -$117K ﹤0.01% 1322
2018
Q1 		$145K Buy
+59,282
New +$178K 0.01% 1321

Other funds holding AXSM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
VMI
VHCP Management III New York $504M AUM 683.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
VMI
VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

A.R.T. Advisors's AXSM Position: Q4 2019 in Review

A.R.T. Advisors sold out of Axsome Therapeutics (AXSM) in Q4 2019, closing a stake of 19,428 shares — an estimated $393K sold.

A.R.T. Advisors first reported a position in AXSM in Q1 2018 and held it in 3 quarters. The position peaked at $393K in Q3 2019. 169 funds tracked by Wall St. Rank hold AXSM as of Q4 2019.

  • A.R.T. Advisors reported no remaining Axsome Therapeutics position as of Q4 2019 after selling out during the quarter.
  • A.R.T. Advisors sold 19,428 Axsome Therapeutics shares in Q4 2019, an estimated $393K.
  • A.R.T. Advisors first reported a position in Axsome Therapeutics in Q1 2018 and held it in 3 quarters.
  • A.R.T. Advisors's Axsome Therapeutics position peaked at $393K in Q3 2019.
  • 169 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q4 2019.

Based on A.R.T. Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.